Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Contribution of Tumor Endothelial Cells in Cancer Progression.

Hida K, Maishi N, Annan DA, Hida Y.

Int J Mol Sci. 2018 Apr 24;19(5). pii: E1272. doi: 10.3390/ijms19051272. Review.

2.

Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance.

Hida K, Maishi N, Akiyama K, Ohmura-Kakutani H, Torii C, Ohga N, Osawa T, Kikuchi H, Morimoto H, Morimoto M, Shindoh M, Shinohara N, Hida Y.

Cancer Sci. 2017 Nov;108(11):2195-2203. doi: 10.1111/cas.13388. Epub 2017 Sep 17.

3.

Tumor endothelial cells accelerate tumor metastasis.

Maishi N, Hida K.

Cancer Sci. 2017 Oct;108(10):1921-1926. doi: 10.1111/cas.13336. Epub 2017 Aug 17. Review.

4.

ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cells.

Hojo T, Maishi N, Towfik AM, Akiyama K, Ohga N, Shindoh M, Hida Y, Minowa K, Fujisawa T, Hida K.

Oncotarget. 2017 Jul 11;8(28):45484-45495. doi: 10.18632/oncotarget.17567.

5.

miR-145 promoted anoikis resistance in tumor endothelial cells.

Hida K, Kawamoto T, Maishi N, Morimoto M, Akiyama K, Ohga N, Shindoh M, Shinohara N, Hida Y.

J Biochem. 2017 Aug 1;162(2):81-84. doi: 10.1093/jb/mvx033.

PMID:
28510655
6.

Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.

Torii C, Hida Y, Shindoh M, Akiyama K, Ohga N, Maishi N, Ohiro Y, Ono M, Totsuka Y, Kitagawa Y, Tei K, Sato Y, Hida K.

Anticancer Res. 2017 Mar;37(3):1219-1225.

PMID:
28314285
7.

ATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy.

Hida K, Kikuchi H, Maishi N, Hida Y.

Cancer Lett. 2017 Aug 1;400:305-310. doi: 10.1016/j.canlet.2017.02.006. Epub 2017 Feb 16. Review.

PMID:
28216371
8.

Tumor endothelial cells express high pentraxin 3 levels.

Hida K, Maishi N, Kawamoto T, Akiyama K, Ohga N, Hida Y, Yamada K, Hojo T, Kikuchi H, Sato M, Torii C, Shinohara N, Shindoh M.

Pathol Int. 2016 Dec;66(12):687-694. doi: 10.1111/pin.12474. Epub 2016 Nov 14.

PMID:
27862647
9.

Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan.

Maishi N, Ohba Y, Akiyama K, Ohga N, Hamada J, Nagao-Kitamoto H, Alam MT, Yamamoto K, Kawamoto T, Inoue N, Taketomi A, Shindoh M, Hida Y, Hida K.

Sci Rep. 2016 Jun 13;6:28039. doi: 10.1038/srep28039.

10.

Tumor angiogenesis--characteristics of tumor endothelial cells.

Hida K, Maishi N, Torii C, Hida Y.

Int J Clin Oncol. 2016 Apr;21(2):206-212. doi: 10.1007/s10147-016-0957-1. Epub 2016 Feb 15. Review.

PMID:
26879652
11.

Heterogeneity of tumor endothelial cells and drug delivery.

Hida K, Maishi N, Sakurai Y, Hida Y, Harashima H.

Adv Drug Deliv Rev. 2016 Apr 1;99(Pt B):140-147. doi: 10.1016/j.addr.2015.11.008. Epub 2015 Nov 26. Review.

PMID:
26626622
12.

CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.

Yamada K, Maishi N, Akiyama K, Towfik Alam M, Ohga N, Kawamoto T, Shindoh M, Takahashi N, Kamiyama T, Hida Y, Taketomi A, Hida K.

Int J Cancer. 2015 Dec 15;137(12):2825-36. doi: 10.1002/ijc.29655. Epub 2015 Jul 2.

13.

Adaptor protein CRK induces epithelial-mesenchymal transition and metastasis of bladder cancer cells through HGF/c-Met feedback loop.

Matsumoto R, Tsuda M, Wang L, Maishi N, Abe T, Kimura T, Tanino M, Nishihara H, Hida K, Ohba Y, Shinohara N, Nonomura K, Tanaka S.

Cancer Sci. 2015 Jun;106(6):709-17. doi: 10.1111/cas.12662. Epub 2015 Apr 22.

14.

Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel.

Akiyama K, Maishi N, Ohga N, Hida Y, Ohba Y, Alam MT, Kawamoto T, Ohmura H, Yamada K, Torii C, Shindoh M, Hida K.

Am J Pathol. 2015 Feb;185(2):572-80. doi: 10.1016/j.ajpath.2014.10.017. Epub 2014 Dec 8.

PMID:
25498238
15.

Identification of tumor endothelial cells with high aldehyde dehydrogenase activity and a highly angiogenic phenotype.

Ohmura-Kakutani H, Akiyama K, Maishi N, Ohga N, Hida Y, Kawamoto T, Iida J, Shindoh M, Tsuchiya K, Shinohara N, Hida K.

PLoS One. 2014 Dec 1;9(12):e113910. doi: 10.1371/journal.pone.0113910. eCollection 2014.

16.

Suprabasin as a novel tumor endothelial cell marker.

Alam MT, Nagao-Kitamoto H, Ohga N, Akiyama K, Maishi N, Kawamoto T, Shinohara N, Taketomi A, Shindoh M, Hida Y, Hida K.

Cancer Sci. 2014 Dec;105(12):1533-40. doi: 10.1111/cas.12549. Epub 2014 Nov 5.

17.

Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells.

Otsubo T, Hida Y, Ohga N, Sato H, Kai T, Matsuki Y, Takasu H, Akiyama K, Maishi N, Kawamoto T, Shinohara N, Nonomura K, Hida K.

Cancer Sci. 2014 May;105(5):560-7. doi: 10.1111/cas.12394. Epub 2014 Apr 19.

18.

Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironment.

Kondoh M, Ohga N, Akiyama K, Hida Y, Maishi N, Towfik AM, Inoue N, Shindoh M, Hida K.

PLoS One. 2013 Nov 15;8(11):e80349. doi: 10.1371/journal.pone.0080349. eCollection 2013.

19.

Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis.

Osawa T, Ohga N, Akiyama K, Hida Y, Kitayama K, Kawamoto T, Yamamoto K, Maishi N, Kondoh M, Onodera Y, Fujie M, Shinohara N, Nonomura K, Shindoh M, Hida K.

Br J Cancer. 2013 Oct 15;109(8):2237-47. doi: 10.1038/bjc.2013.535. Epub 2013 Sep 17.

20.

Heterogeneity of tumor endothelial cells.

Hida K, Ohga N, Akiyama K, Maishi N, Hida Y.

Cancer Sci. 2013 Nov;104(11):1391-5. doi: 10.1111/cas.12251. Epub 2013 Sep 12. Review.

21.

Application of POLARICâ„¢ fluorophores in an in vivo tumor model.

Maishi N, Kawamoto T, Ohga N, Yamada K, Akiyama K, Yamamoto K, Osawa T, Hida Y, Hida K.

Oncol Rep. 2013 Oct;30(4):1695-700. doi: 10.3892/or.2013.2620. Epub 2013 Jul 18.

PMID:
23877868
22.

The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma.

Akiyama K, Ohga N, Maishi N, Hida Y, Kitayama K, Kawamoto T, Osawa T, Suzuki Y, Shinohara N, Nonomura K, Shindoh M, Hida K.

Pathol Int. 2013 Jan;63(1):37-44. doi: 10.1111/pin.12031.

PMID:
23356224
23.

Tumour endothelial cells acquire drug resistance in a tumour microenvironment.

Hida K, Akiyama K, Ohga N, Maishi N, Hida Y.

J Biochem. 2013 Mar;153(3):243-9. doi: 10.1093/jb/mvs152. Epub 2013 Jan 3. Review.

PMID:
23293323
24.

CXCR7: a novel tumor endothelial marker in renal cell carcinoma.

Maishi N, Ohga N, Hida Y, Akiyama K, Kitayama K, Osawa T, Onodera Y, Shinohara N, Nonomura K, Shindoh M, Hida K.

Pathol Int. 2012 May;62(5):309-17. doi: 10.1111/j.1440-1827.2012.02792.x. Epub 2012 Feb 21.

PMID:
22524658
25.

Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis.

Kawamoto T, Ohga N, Akiyama K, Hirata N, Kitahara S, Maishi N, Osawa T, Yamamoto K, Kondoh M, Shindoh M, Hida Y, Hida K.

PLoS One. 2012;7(3):e34045. doi: 10.1371/journal.pone.0034045. Epub 2012 Mar 30.

26.

Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells.

Yamamoto K, Ohga N, Hida Y, Maishi N, Kawamoto T, Kitayama K, Akiyama K, Osawa T, Kondoh M, Matsuda K, Onodera Y, Fujie M, Kaga K, Hirano S, Shinohara N, Shindoh M, Hida K.

Br J Cancer. 2012 Mar 13;106(6):1214-23. doi: 10.1038/bjc.2012.59. Epub 2012 Feb 28.

27.

Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment.

Akiyama K, Ohga N, Hida Y, Kawamoto T, Sadamoto Y, Ishikawa S, Maishi N, Akino T, Kondoh M, Matsuda A, Inoue N, Shindoh M, Hida K.

Am J Pathol. 2012 Mar;180(3):1283-93. doi: 10.1016/j.ajpath.2011.11.029. Epub 2012 Jan 13.

PMID:
22245726
28.

Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumors.

Ohga N, Ishikawa S, Maishi N, Akiyama K, Hida Y, Kawamoto T, Sadamoto Y, Osawa T, Yamamoto K, Kondoh M, Ohmura H, Shinohara N, Nonomura K, Shindoh M, Hida K.

Am J Pathol. 2012 Mar;180(3):1294-307. doi: 10.1016/j.ajpath.2011.11.035. Epub 2012 Jan 12.

PMID:
22245217
29.

HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium.

Kurosu T, Ohga N, Hida Y, Maishi N, Akiyama K, Kakuguchi W, Kuroshima T, Kondo M, Akino T, Totsuka Y, Shindoh M, Higashino F, Hida K.

Br J Cancer. 2011 Mar 1;104(5):819-29. doi: 10.1038/bjc.2011.20. Epub 2011 Feb 1.

Supplemental Content

Loading ...
Support Center